CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-27 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −8,048 | 239,354 | ||
| 2023-03-27 | Harris Todd Chief Executive Officer | Option exercise | +2,963 | $2.25 | $7K | 1,704,239 |
| 2023-03-27 | Harris Todd Chief Executive Officer | Sale | −2,963 | $16.00 | $47K | 1,701,276 |
| 2023-03-27 | Harris Todd Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −2,963 | 406,643 | ||
| 2023-03-24 | Harris Todd Chief Executive Officer | Option exercise | +170 | $2.25 | $383 | 1,701,446 |
| 2023-03-24 | Harris Todd Chief Executive Officer | Sale | −170 | $16.00 | $3K | 1,701,276 |
| 2023-03-24 | Harris Todd Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −170 | 409,606 | ||
| 2023-03-23 | Harris Todd Chief Executive Officer | Option exercise | +2,800 | $2.25 | $6K | 1,704,076 |
| 2023-03-23 | Harris Todd Chief Executive Officer | Sale | −2,800 | $16.00 | $45K | 1,701,276 |
| 2023-03-23 | Harris Todd Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −2,800 | 409,776 | ||
| 2023-03-23 | Bensen Daniel Chief Operating Officer | Option exercise | +4,827 | $0.61 | $3K | 532,808 |
| 2023-03-23 | Bensen Daniel Chief Operating Officer | Sale | −4,827 | $16.00 | $77K | 527,981 |
| 2023-03-23 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −4,827 | 247,402 | ||
| 2023-03-22 | Harris Todd Chief Executive Officer | Option exercise | +4,043 | $2.25 | $9K | 1,705,319 |
| 2023-03-22 | Harris Todd Chief Executive Officer | Sale | −4,043 | $16.00 | $65K | 1,701,276 |
| 2023-03-22 | Harris Todd Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −4,043 | 412,576 | ||
| 2023-03-22 | Bensen Daniel Chief Operating Officer | Option exercise | +3,800 | $0.61 | $2K | 531,781 |
| 2023-03-22 | Bensen Daniel Chief Operating Officer | Sale | −3,800 | $16.00 | $61K | 527,981 |
| 2023-03-22 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −3,800 | 252,229 | ||
| 2023-03-21 | Harris Todd Chief Executive Officer | Option exercise | +12,393 | $2.25 | $28K | 1,713,669 |
Page 15 of 21 · 417 trades